" /> CD34 dose in hematopoietic progenitor cell transfusion:NCnt:Pt: Patient:Qn: - CISMeF





Preferred Label : CD34 dose in hematopoietic progenitor cell transfusion:NCnt:Pt: Patient:Qn:;

LOINC status : ACTIVE;

LOINC display name : CD34 dose in hematopoietic progenitor cell transfusion [#/Mass];

LOINC long common name : CD34 dose in hematopoietic progenitor cell transfusion [#/mass] per recipient body mass;

LOINC short name : CD34 dose in HPC per recipient body mass;

LOINC description : Autologous hematopoietic progenitor cell (HPC) transplant is used to treat hematologic malignancies in children, adolescents, and young adults. The dose of CD34 cells in the transplant, calculated as the number of CD34 cells infused per kg of the transplant recipient's body weight, is associated with the success of engraftment and patient morbidity and mortality, with higher doses yielding better clinical outcomes. The minimum CD34 cell dose to achieve fast and effective engraftment is 2-5 10 6 cells/kg. [PMID: 26041417];

Détails


Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.